CNPFX
Price
$70.43
Change
-$0.43 (-0.61%)
Updated
Jan 14 closing price
Net Assets
162.72B
LSCGX
Price
$22.39
Change
-$0.30 (-1.32%)
Updated
Jan 14 closing price
Net Assets
134.79M
Interact to see
Advertisement

CNPFX vs LSCGX

Header iconCNPFX vs LSCGX Comparison
Open Charts CNPFX vs LSCGXBanner chart's image
American Funds New Perspective 529F
Price$70.43
Change-$0.43 (-0.61%)
VolumeN/A
Net Assets162.72B
Loomis Sayles Global Growth C
Price$22.39
Change-$0.30 (-1.32%)
VolumeN/A
Net Assets134.79M
CNPFX vs LSCGX Comparison Chart in %
View a ticker or compare two or three
VS
CNPFX vs. LSCGX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPFX is a Hold and LSCGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPFX has more cash in the bank: 163B vs. LSCGX (135M). CNPFX pays higher dividends than LSCGX: CNPFX (1.20) vs LSCGX (0.00). CNPFX was incepted earlier than LSCGX: CNPFX (23 years) vs LSCGX (10 years). LSCGX (2.13) is less costly to investors than CNPFX (0.84). CNPFX is a more actively managed with annual turnover of: 24.00 vs. LSCGX (6.00). CNPFX has a lower initial minimum investment than LSCGX: CNPFX (250) vs LSCGX (2500). LSCGX annual gain was more profitable for investors over the last year : 20.05 vs. CNPFX (18.19). LSCGX return over 5 years is better than : 25.71 vs. CNPFX (21.42).
CNPFXLSCGXCNPFX / LSCGX
Total Expense Ratio0.841.9543%
Annual Report Gross Expense Ratio0.842.1339%
Fund Existence23 years10 years-
Gain YTD2.2211.886118%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets163B135M120,741%
Annual Yield % from dividends1.200.00-
Returns for 1 year18.1920.0591%
Returns for 3 years47.4177.8261%
Returns for 5 years21.4225.7183%
Returns for 10 years139.62N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWOMX19.45N/A
N/A
Fidelity Women's Leadership
CMRGX10.21N/A
N/A
Calamos Merger Arbitrage I
BRWCX25.88-0.06
-0.23%
MFS Blended Research Growth Eq C
JFNSX77.45-0.23
-0.30%
Janus Henderson Global Life Sciences S
GIEYX16.25-0.11
-0.67%
GuideStone Funds International Eq Instl